SGDV Jahreskongress 2025
zurück zur Veranstaltungswebsite
Converia – Conference Management Software

Detaillierte Beitrags-Information

Zurück zur Liste

Beitragstitel Nemolizumab was associated with rapid and significant improvements in itch and sleep in patients with moderate-to-severe atopic dermatitis: Results from two global phase 3 pivotal studies (ARCADIA 1 and ARCADIA 2)
Autoren
  1. Jonathan Silverberg George Washington University School of Medicine and Health Sciences
  2. Andreas Wollenberg Dept. of Dermatology and Allergy, University Hospital Augsburg. Dept. of Dermatology and Allergy, Ludwig-Maximilian University.Comprehensive Center for Inflammation Medicine, University of Luebeck
  3. Linda Stein-Gold Henry Ford Health System
  4. Diamant Thaçi University of Lübeck, Germany
  5. Andrew Pink St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust
  6. Kim A. Papp Alliance Clinical Trials and Probity Medical ResearchWaterloo, Ontario, Canada. University of Toronto, Toronto, Ontario, Canada
  7. Franz J. Legat Department of Dermatology and Venereology, Medical University of Graz
  8. Vivian T. Laquer The First OC Dermatology Research
  9. Soo Yeon Cheong Galderma
  10. Liliana Ulianov Galderma
  11. Anna Ryzhkova Galderma
  12. Christophe Piketty Galderma
  13. Marlene Gassner Galderma SA Vortragender
Präsentationsform Poster
Themengebiete
  • 1.1 Inflammatory and immune-mediated dermatoses